Featured Policy

A new AAP technical report provides a comprehensive review of the evidence-based literature surrounding abusive head trauma, which can help pediatricians communicate scientific information to child welfare agencies, the courts and others.

The AAP urges primary care providers ask three questions to identify an infant with liver disease during the 2-4 week well-child visit, along with other recommendations in a new clinical report. Biliary atresia accounts for 60% of liver transplants in infants younger than 1 year and 30% of all liver transplants in pediatric patients. 

The AAP approved the 2025 schedule, which outlines recommended screenings and assessments for patients from birth to age 21. No changes have been made to clinical guidance or footnotes in the 2025 Recommendations for Preventive Pediatric Health Care (Periodicity Schedule).

Pediatricians and pediatric trainees in North America are increasingly involved in caring for children and adolescents in or from low- and middle-income countries (LMICs). In many LMICs, toxic environmental exposures are highly prevalent and account for twice as great a proportion of disease and deaths among young children as in North America.

This report aims to review recent advances in the understanding of fracture specificity, fracture mechanisms, and other medical conditions that predispose infants and children to fracture. This clinical report will aid pediatricians and pediatric care providers in developing an evidence-based differential diagnosis and performing appropriate evaluations when assessing a child with fractures.

This clinical report provides 3 updated recommendations. First, a new AAP algorithm has been endorsed for use in CCHD screening. Compared with the original AAP algorithm from 2011, this new algorithm a) has a passing oxygen saturation threshold of ≥95% in both pre- and post-ductal measurements; and b) has only 1 retest instead of 2 for infants who did not pass the first screen. Second, to continue to improve screening, state newborn screening programs should collect a recommended minimum uniform dataset to aid in surveillance and monitoring of the program. Finally, stakeholders should be educated on the limitations of screening, the significance of non-CCHD conditions, and the importance of protocol adherence